NASDAQ: PIRS       Pieris Pharma
Last Price Today's Change   Day's Range   Trading Volume
3.88   +0.29 (8.08%)  3.52 - 3.93  1,568,900


Avg Volume (4 weeks):0
52 Weeks Range:1.70 - 6.06
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343 and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm is functioned through the region of US.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

6384  3847  863  629 

Top 10 Active Counters
 EFOI 3.32+1.37 
 SQQQ 5.98-0.07 
 DARE 2.13+0.008 
 XELA 1.26+0.12 
 AAPL 174.41+3.23 
 SNDL 0.617+0.019 
 ITUB 4.040.00 
 TLGT 0.174-0.028 
 SPY 469.52+1.24 
 ISIG 19.11+8.73